Patents Assigned to Eisal R&D Management Co., Ltd.
  • Patent number: 8053580
    Abstract: It is an object of the present invention to provide (1) a process for manufacturing alkali metal salts of 2-[{4-(3-methoxypropoxy)-3-methylpyridin-2-yl}methylsulfinyl]-1H-benzimidazole which are useful as gastric acid secretion inhibitors, anti-ulcer agents and other drugs and (2) salts of 2-[{4-(3-methoxypropoxy)-3-methylpyridin-2-yl}methylsulfinyl]-1H-benzimidazole with amines which are intermediates for the production of the alkali metal salts, and a process for manufacturing the same. According to the present invention, disclosed are salts represented by the following formula (I): (wherein A+ represents an isopropylammonium ion, sec-butylammonium ion or cyclopentylammonium ion).
    Type: Grant
    Filed: June 24, 2009
    Date of Patent: November 8, 2011
    Assignee: Eisal R&D Management Co., Ltd.
    Inventors: Hiroyuki Yokoi, Masanori Mizuno, Toyokazu Haga
  • Publication number: 20070259383
    Abstract: A high-throughput in situ hybridization system was applied to the mouse foot pad epidermis to identify novel genes involved in epidermal differentiation. As a result, epidermal expression patterns were detected for about 100 unique mRNAs. Of these, two novel secreted proteins, dermokine-? and -?, which are expressed in the suprabasal layer of the differentiated epithelia, were successfully identified. Further, the gene encoding the above proteins was found to constitute a novel gene complex (SSC).
    Type: Application
    Filed: March 2, 2005
    Publication date: November 8, 2007
    Applicant: EISAL R&D MANAGEMENT CO., LTD
    Inventors: Takeshi Matsui, Fumie Kisumi, Yoko Kinoshita